Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:8:p2
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 8 (pt 2/2)
Character Range: 433538–434890

Schedule 2 or 4.
OXYCODONE.
OXYMORPHONE.
PENTAZOCINE.
# PENTOBARBITAL except when included in Schedule 4.
PETHIDINE.
PHENDIMETRAZINE.
PHENMETRAZINE.
PHENOPERIDINE.
4‑PHENYLPIPERIDINE‑4‑CARBOXYLIC ACID ETHYL ESTER (Pethidine intermediate B).
PHOLCODINE except when included in Schedule 2 or 4.
PIRITRAMIDE.
PROPIRAM.
# PSILOCYBINE in preparations for human therapeutic use for the treatment of treatment‑resistant depression.
RACEMORAMIDE.
REMIFENTANIL.
SECBUTOBARBITAL.
SECOBARBITAL.
# SODIUM OXYBATE for human therapeutic use.
SUFENTANIL.
TAPENTADOL.
# TETRAHYDROCANNABINOLS when extracted from cannabis for human therapeutic use, when:

       (a) included in products manufactured in accordance with the Narcotic Drugs Act 1967; and/or

       (b) imported as therapeutic goods, or for use in therapeutic goods, for supply, in accordance with the Act; and/or

       (c) in therapeutic goods supplied in accordance with the Act;

     except when:

       (d) it is in a product to which item 4, 8, 10, 11 or 12 of Schedule 5A to the Therapeutic Goods Regulations 1990 applies; or

       (e) separately specified in the NABIXIMOLS entry in this Schedule; or

       (f) captured by the CANNABIDIOL entry in Schedule 4 or Schedule 3; or

       (g) in hemp seed oil at a concentration of 10 mg/kg or less.
THEBACON.
THEBAINE.
THIAFENTANIL.
TILIDINE.